LD
Lisa Lynn Decker
Chief Business Officer

Lisa Lynn Decker insider trades: IGM Biosciences (IGMS) stock sales

Chief Business Officer, IGM Biosciences Last trade Jul 23, 2025 28 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
14
Open-market trades
since 2022
3
Companies
last trade 2025

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Lisa reports to the SEC

Open-market buys and sales

14 trades reported on SEC Form 4, newest first

DateStockTypeValue
Jul 23, 2025IGMS↓ Sell$6K
Jun 16, 2025IGMS↓ Sell$1K
Mar 14, 2025IGMS↓ Sell$6K
Dec 16, 2024IGMS↓ Sell$8K
Sep 13, 2024IGMS↓ Sell$11K
Jun 14, 2024IGMS↓ Sell$7K
Mar 14, 2024IGMS↓ Sell$34K
Dec 13, 2023IGMS↓ Sell$25K
Nov 29, 2023IGMS↓ Sell$7K
May 23, 2023IGMS↓ Sell$15K
Mar 14, 2023IGMS↓ Sell$20K
Dec 16, 2022IGMS↓ Sell$47K
Nov 23, 2022IGMS↓ Sell$27K
May 24, 2022IGMS↓ Sell$23K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About Lisa Lynn Decker's insider trades

Lisa Lynn Decker is Chief Business Officer at IGM Biosciences (IGMS). Since May 24, 2022, Lisa has reported no open-market purchases and 14 sales worth $238K on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include grants and awards (14 filings), shares returned to the company (2 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every IGMS insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.